• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>AIDS care. >Access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region 2002-2006
【24h】

Access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region 2002-2006

机译：世卫组织欧洲区域2002-2006年为妇女和儿童提供的高效抗逆转录病毒疗法（HAART）

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective. To assess the level of access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region. Methods. Analysis of data from three national surveys of 53 WHO European Member States. The comparative level of access to HAART for women and children was assessed by comparing the percentage of reported HIV cases with the percentage of HAART recipients in women at the end of 2002 and 2006 and in children at the end of 2004 and 2006. Findings. Overall, the data suggest that there is equivalence of access to antiretroviral therapy by gender and age in Europe. However, in central and eastern Europe women were disproportionately more likely to receive HAART when compared with men in 2006, representing 29% of HIV cases when compared with 39% of HAART recipients in central Europe, and 34% of HIV cases when compared with 42% of HAART recipients in eastern Europe. In comparison with adults, children ( < 15 years of age) were over-represented among HAART recipients when compared with HIV cases in eastern Europe, accounting for 1% of HIV cases and 9% of people on HAART in 2004 and 1% of HIV cases and 8% HAART recipients in 2006. Conclusion. Access to HAART remains inequitable in terms of gender in central and eastern Europe, favouring women over men, and in terms of age in eastern Europe, favouring children over adults. Despite high and increasing coverage with HAART in many European countries, countries must address how to further increase the number of people on treatment while ensuring equitable access for all population groups in need.
机译：目的。评估世卫组织欧洲区域妇女和儿童获得高活性抗逆转录病毒疗法（HAART）的水平。方法。分析来自53个世卫组织欧洲会员国的三次国家调查的数据。通过比较2002年和2006年底妇女以及2004年底和2006年底妇女和儿童中报告的艾滋病毒病例百分比和接受HAART接受者的百分比，评估了妇女和儿童获得HAART的相对水平。总体而言，数据表明在欧洲，按性别和年龄，获得抗逆转录病毒疗法的人数相当。但是，在中欧和东欧，与2006年的男性相比，女性更容易接受HAART，占HIV病例的29％，而中欧只有39％的HAART接受者，占HIV病例的34％，与42东欧HAART接收者的百分比。与成人相比，与东欧的HIV病例相比，HAART接受者中儿童（<15岁）的人数过多，在2004年占HIV病例的1％，在HAART人群中占9％，在HIV中占1％病例和2006年有8％的HAART接受者。结论。就中欧和东欧的性别而言，获得HAART的机会仍然不平等，在妇女方面，男性胜于男性;在东欧的年龄方面，儿童则胜于成人。尽管在许多欧洲国家，HAART的覆盖率不断提高，但各国仍必须解决如何进一步增加接受治疗的人数，同时确保所有需要治疗的人群都能平等获得治疗的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号